Cabaletta Bio Inc.

NASDAQ: CABA · Real-Time Price · USD
1.71
0.06 (3.64%)
At close: Aug 15, 2025, 2:36 PM

Cabaletta Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
4.81M 1.43M 3.68M 733K
Gross Profit
-4.81M -1.43M -3.68M -733K
Operating Income
-125.14M -74.66M -54.14M -46.31M
Interest Income
10.03M 6.99M 1.16M 24K
Pretax Income
-115.86M -67.67M -52.98M -46.29M
Net Income
-115.86M -67.67M -52.98M -46.29M
Selling & General & Admin
27.94M 19.24M 14.84M 13.82M
Research & Development
97.2M 55.42M 39.3M 32.49M
Other Expenses
n/a -1.43M n/a n/a
Operating Expenses
125.14M 73.23M 54.14M 46.31M
Interest Expense
748K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
125.14M 74.66M 54.14M 46.31M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
49.52M 40.95M 29.34M 25.74M
Shares Outstanding (Diluted)
49.47M 40.95M 29.34M 25.74M
EPS (Basic)
-2.34 -1.65 -1.81 -1.8
EPS (Diluted)
-2.34 -1.65 -1.81 -1.8
EBITDA
-125.14M -73.23M -52.96M -45.58M
EBIT
-116.61M -67.67M -52.98M -46.31M
Depreciation & Amortization
-8.53M 1.43M 1.18M 733K